Cohance Lifesciences Limited (NSE:COHANCE)
India · Delayed Price · Currency is INR 910.00
-76.05 (-7.71%)
Aug 14, 2025, 3:29 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 349.61 billion as of August 14, 2025. Its market cap has increased by 53.14% in one year.
Market Cap
349.61B
Enterprise Value
351.04B
Revenue
12.54B
Ranking
n/a
PE Ratio
97.26
Stock Price
910.00
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 349.61B, an increase of 1,037,161.48%. That is a compound annual growth rate of 448.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 377.23B | 30.13% |
| Dec 31, 2024 | 289.89B | 57.55% |
| Dec 29, 2023 | 184.00B | 46.05% |
| Dec 30, 2022 | 125.98B | 0.33% |
| Dec 31, 2021 | 125.56B | 9.05% |
| Dec 31, 2020 | 115.14B | 341,510.23% |
| Mar 9, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,938.27B |
| Divi's Laboratories | 1,627.99B |
| Cipla | 1,263.32B |
| Apollo Hospitals Enterprise | 1,124.61B |
| Mankind Pharma | 1,020.51B |
| Zydus Lifesciences | 994.96B |
| Fortis Healthcare | 714.04B |
| Alkem Laboratories | 644.28B |